Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study

International Journal of Cancer

Volumn 136, Issue 8, 2015, Pages 1899-1908

  Bamia, Christina ^a   Lagiou, Pagona ^a,b,c   Jenab, Mazda ^d   Trichopoulou, Antonia ^a,e   Fedirko, Veronika ^d,f   Aleksandrova, Krasimira ^g   Pischon, Tobias ^g,h   Overvad, Kim ⁱ   Olsen, Anja ^j   Tjønneland, Anne ^j   Boutron Ruault, Marie Christine ^k,l,m   Fagherazzi, Guy ^k,l,m   Racine, Antoine ^k,l,m   Kuhn, Tilman ⁿ   Boeing, Heiner ^g   Floegel, Anna ^g   Benetou, Vasiliki ^a,e   Palli, Domenico ^o   Grioni, Sara ^p   Panico, Salvatore ^q   Tumino, Rosario ^r   Vineis, Paolo ^s   Bueno De Mesquita, H B ^t,u,v   Dik, Vincent K ^v   Bhoo Pathy, Nirmala ^v,w   Uiterwaal, Cuno S P M ^v   Weiderpass, Elisabete ^x,y,z,aa   Lund, Eiliv ^x   Quirós, J Ramón ^ab   Zamora Ros, Raul ^d,ac   Molina Montes, Esther ^ad,ae,af   Chirlaque, Maria Dolores ^af,ag   Ardanaz, Eva ^af,ah   Dorronsoro, Miren ^ai,aj   Lindkvist, Björn ^ak   Wallström, Peter ^al   Nilsson, Lena Maria ^am   Sund, Malin ^am   Khaw, Kay Tee ^an   Wareham, Nick ^an   Bradbury, Kathryn E ^ao   Travis, Ruth C ^ao   Ferrari, Pietro ^d   Duarte Salles, Talita ^d   Stepien, Magdalena ^d   Gunter, Marc ^t   Murphy, Neil ^t   Riboli, Elio ^t   Trichopoulos, Dimitrios ^b,c,e   more..

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e HELLENIC HEALTH FOUNDATION   (Greece)

^f EMORY UNIVERSITY   (United States)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

ⁱ AARHUS UNIVERSITY   (Denmark)

^j DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^k INSTITUT GUSTAVE ROUSSY   (France)

^l UNIVERSITÉ PARIS SACLAY   (France)

^m IGR   (France)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^r CIVILE M P AREZZO HOSPITAL   (Italy)

^s Human Genetics Foundation (HuGeF)   (Italy)

^t IMPERIAL COLLEGE LONDON   (United Kingdom)

^u NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^v UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^w UNIVERSITY OF MALAYA   (Malaysia)

^x UNIVERSITY OF TROMSØ   (Norway)

^y CANCER REGISTRY OF NORWAY   (Norway)

^z KAROLINSKA INSTITUTE   (Sweden)

^aa FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ab Health Department of the Autonomous Government of Asturias   (Spain)

^ac CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ad ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ae Instituto Biosanitario de Granada ibs GRANADA   (Spain)

^af CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^ag DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ah INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ai Basque Government   (Spain)

^aj BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ak UNIVERSITY OF GOTHENBURG   (Sweden)

^al LUND UNIVERSITY   (Sweden)

^am UMEÅ UNIVERSITY   (Sweden)

^an UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ao UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Coffee; EPIC; Hepatocellular carcinoma; Liver cancer; Tea

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COFFEE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECAFFEINATED COFFEE; EUROPEAN; FEMALE; FOOD INTAKE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MALE; MULTICENTER STUDY; NUTRITIONAL VALUE; PROSPECTIVE STUDY; TEA; ADVERSE EFFECTS; BEVERAGE; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; EUROPE; INCIDENCE; LIVER NEOPLASMS; MIDDLE AGED; RISK; RISK ASSESSMENT; RISK FACTOR;

CAFFEINE; COFFEE; TEA;

BEVERAGES; CAFFEINE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COFFEE; EUROPE; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; RISK ASSESSMENT; RISK FACTORS; TEA;

EID: 84922567205     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29214     Document Type: Article

References (43)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-76.
2. Schlesinger S, Aleksandrova K, Pischon T, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 2013;132:645-57.
3. International Agency for Research on Cancer. Aflatoxins. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 82. Traditional herbal medicines, some mycotoxins, naphthalene and styrene. Lyon, France: IARC Press, 2002.
4. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009;286:9-14.
5. Hu G, Tuomilehto J, Pukkala E, et al. Joint effects of coffee consumption and serum gammaglutamyltransferase on the risk of liver cancer. Hepatology 2008;48:129-36.
6. Lai GY, Weinstein SJ, Albanes D, et al. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer 2013;109:1344-51.
7. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR, 2007.
8. Bravi F, Bosetti C, Tavani A, et al. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 2013;11:1413-21.
9. Fon Sing M, Yang WS, Gao S, et al. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. Eur J Cancer Prev 2011;20:157-65.
10. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
11. Slimani N, Fahey M, Welch AA, et al. Diversity of dietary patterns observed in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr 2002;5:1311-28.
12. Slimani N, Deharveng G, Unwin I, et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 2007;61:1037-56.
13. Trichopoulos D, Bamia C, Lagiou P, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 2011;103:1686-95.
14. Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 2006;36:201-8.
15. Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 2007;98:214-8.
16. Leung WW, Ho SC, Chan HL, et al. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study. J Epidemiol Community Health 2011;65:556-8.
17. Inoue M, Yoshimi I, Sobue T, et al.; JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005;97:293-300.
18. Kurozawa Y, Ogimoto I, Shibata A, et al.; JACC Study Group. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005;93:607-10.
19. Shimazu T, Tsubono Y, Kuriyama S, et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005;116:150-4.
20. Ohishi W, Fujiwara S, Cologne JB, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:846-54.
21. Inoue M, Kurahashi N, Iwasaki M, et al.; Japan Public Health Center-Based Prospective Study Group. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009;18:1746-53.
22. Johnson S, Koh WP, Wang R, et al. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 2011;22:503-10.
23. Gallus S, Bertuzzi M, Tavani A, et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer 2002;87:956-9.
24. Gelatti U, Covolo L, Franceschini M, et al.; Brescia HCC Study Group. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005;42:528-34.
25. Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 2007;120:1555-9.
26. Kuper H, Tzonou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000;85:498-502.
27. Kanazir M, Boricic I, Delic D, et al. Risk factors for hepatocellular carcinoma: a case-control study in Belgrade (Serbia). Tumori 2010;96:911-7.
28. Wang JY, Zhu L, Wu DL, et al. Matched case-control study on factors for main cancer in a low incidence area of Jiangsu province. Chin J Cancer Prev Treat 2008;15:565-8.
29. Ui A, Kuriyama S, Kakizaki M, et al. Green tea consumption and the risk of liver cancer in Japan: the Ohsaki cohort study. Cancer Causes Control 2009;20:1939-45.
30. Chen SD, Zhang GQ, Lian JH. A case-control study of primary liver cancer in Guangdong province of China. Chin J Public Health 1999;18:231-2.
31. Mu LN, Zhou XF, Ding BG, et al. A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Chin J Epidemiol 2003;24:192-5.
32. Mu LN, Zhou XF, Ding BG, et al. Study on the protective effect of green tea on gastric, liver and esophageal cancers. Chin J Prev Med 2003;37:171-3.
33. Nakachi K, Matsuyama S, Miyake S, et al. Preventive effects of drinking green tea on cancer and cardio vascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000;13:49-54.
34. Nagano J, Kono S, Preston DL, et al. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 2001;12:501-8.
35. Tang BM, Bian JC, Wang QJ, et al. The case-control study for the risk factors of HCC in Luoyang. Modern Prev Med 2002;29:723-5.
36. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005;129:1928-36.
37. Saab S, Mallam D, Cox GA II, et al. Impact of coffee on liver diseases: a systematic review. Liver Int 2014;34:495-504. doi: 10.1111/liv. 12304.
38. Corrao G, Zambon A, Bagnardi V, et al. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001;11:458-65.
39. Huxley R, Lee CM, Barzi F, et al. Coffee. Decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus. A systematic review with meta-analysis. Arch Intern Med 2009;169:2053-63.
40. Torres DM, Harrison SA. Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology 2009;144:670-2.
41. Cavin C, Holzhaeuser D, Scharf G, et al. Cafestol and kahweol, two coffee specific diterpenes with anticarcino-Genic activity. Food Chem Toxicol 2002;40:1155-63.
42. Moreira DP, Monteiro MC, Ribeiro-Alves M, et al. Contribution of chlorogenic acids to the iron-reducing activity of coffee beverages. J Agric Food Chem 2005;53:1399-402.
43. Darvesh AS, Bishayee A. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr Cancer 2013;65:329-44.